征稿已开启

查看我的稿件

注册已开启

查看我的门票

已截止
活动简介

On behalf of the Organizing Committee, it is my great pleasure to invite you to participate in the International Academy of Cardiology, Annual Scientific Sessions 2017, 22nd WORLD CONGRESS ON HEART DISEASE, Vancouver, BC, Canada, July 14-16, 2017.
The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.
Plans for this CME meeting are progressing extremely well. Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.
Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials. We hope that you will participate in this Congress and submit for presentation your most recent scientific work in the rapidly evolving field of cardiovascular disease.
Your interaction with your colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding. We look forward to your active participation in the 22nd WORLD CONGRESS ON HEART DISEASE and to welcoming you to the beautiful city of Vancouver in July.

征稿信息

重要日期

2017-02-09
初稿截稿日期

征稿范围

MOLECULAR CARDIOLOGY, BASIC RESEARCH

  • Apoptosis in vascular and cardiac remodeling

  • Oxidative stress and anti-oxidant therapy

  • Genetic determinants of coronary heart disease

  • Genetic studies in cardiomyopathy

  • Gene transfer and therapy

  • The pathogenesis of atherosclerosis

  • Extracellular matrix and atherosclerosis

  • Immunological principles in coronary artery disease

  • Growth control and cytokines in vascular cells

  • Neointimal hyperplasia and vascular injury

  • Pharmacologic modulation of vascular-endothelial function

DIAGNOSTIC METHODS

  • Biochemical markers of acute ischemia

  • Transesophageal echocardiography

  • Pharmacologic stress testing - echocardiography

  • Echocardiography, three-dimensional reconstruction

  • Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability

  • PET - new insights into myocardial metabolism

  • Applications of cardiac magnetic resonance imaging

  • CT and coronary calcification

  • Percutaneous coronary angioscopy

  • Intravascular ultrasound imaging

  • Intracoronary flow, doppler measurements

CORONARY ARTERY DISEASE

  • The plaque and acute coronary syndromes

  • Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning

  • Acute myocardial infarction: thrombolysis and reperfusion

  • Angioplasty therapy for acute myocardial infarction

  • Stents: new devices/optimal application/multiple stents

  • Antithrombotic and antiplatelet adjunctive therapy for PTCA

  • Blockade of tissue proliferation after coronary interventions

  • Restenosis - use of ionizing radiation

  • Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction

  • Left ventricular remodeling after myocardial infarction

  • Assessment of prognosis, post acute myocardial infarction

  • Secondary prevention, risk stratification

  • Cardiac rehabilitation as secondary prevention: is it worth the effort?

  • Can the progress of atherosclerosis be halted?

  • Modification of lipoproteins and coronary disease

  • Hypertension, new therapeutic approaches

  • Diabetes mellitus, obesity, insulin and atherosclerosis

  • Mental stress: its effect on cardiovascular health

  • Primary prevention of coronary artery disease in the healthy adult

  • Hormone therapy in postmenopausal women: does it alter coronary risk?

  • Prevention in children

HEART FAILURE

  • Neurohumoral, immunologic and cytokine aspects of heart failure

  • Nitric oxide and nitric oxide synthase in heart failure

  • Myocyte and receptor abnormalities in heart failure

  • Natriuretic peptides, endothelin: role in heart failure

  • Inflammatory mediators and heart failure

  • Dilated cardiomyopathy: various etiologies

  • Ischemic cardiomyopathy

  • Left ventricular hypertrophy and hypertrophic cardiomyopathy

  • Role of the pericardium, pericarditis and restrictive cardiomyopathy

  • Pathophysiologic and prognostic insights in valvular heart disease

  • Pulmonary circulation aspects, pulmonary hypertension

  • Predictors and markers of heart failure outcome

  • Exercise physiology in heart failure

  • Renal aspects - diuretics

  • Digoxin and other new inotropic agents in heart failure

  • ACE inhibitors and Angiotensin-ll receptor blockers

  • Beta-blockers and beta-adrenergic receptors in heart failure

  • Calcium channel blockers and promoters in heart failure

  • Cardiac pacing strategies in heart failure

ARRHYTHMIAS

  • Arrhythmias and antiarrhythmic drug therapy

  • Atrial flutter/fibrillation - electrophysiologic concepts and clinical aspects

  • Management of cardiac arrhythmias pediatric population

  • Heart rate variability and prognostic implications

  • QT prolongation/dispersion: pathophysiology and prognostic implications

  • Sudden death

  • Electrophysiologic techniques of mapping and radiofrequency ablation

  • Advances in internal defibrillation and implantable antiarrhythmic devices

  • Cardiac Pacing

CARDIAC SURGERY

  • Advances in congenital heart disease

  • Angioplasty or surgery for multivessel coronary artery disease

  • New approaches to surgical revascularization: Minimally invasive surgery, TMLR

  • Therapeutic and physiologic issues surrounding heart valve surgery

  • Mechanical support left ventricular assist devices

  • Surgery for LV dysfunction

  • Cardiac transplantation

MISCELLANEOUS

  • Practice guidelines, cost containment

  • Computers in cardiology

留言
验证码 看不清楚,更换一张
全部留言
重要日期
  • 会议日期

    07月14日

    2017

    07月16日

    2017

  • 02月09日 2017

    初稿截稿日期

  • 07月16日 2017

    注册截止日期

联系方式
移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询